Company | Disease Target | Status |
---|---|---|
Alza | CNS disease | Preclinical |
American Cyanamid | Anti-ras ribozymes | Preclinical |
Columbia University | Anti-bcl-2 ribozymes | Preclinical |
Gene Shears | Anti-HIV-1 ribozymes | Phase I/II |
Immusol | Anti-HIV ribozymes | Phase I/II |
HBV, HCV, restenosis | Preclinical | |
Innovir | HBV, HCV, CML | Preclinical |
Osaka University | Anti-HCV ribozymes | Preclinical |
Ribozyme Pharmaceuticals Inc. | HIV-1 infection | Phase I/II |
Angiogenesis | Preclinical | |
Tokyo University | HCV ribozyme | Preclinical |
University of Pittsburgh | Glioma | Preclinical |
City of Hope | HIV-1 infection | Phase I/II |
CNS, central nervous system; HBV, hepatitis B virus; HCV, hepatitis C virus.